Neonatal Outcomes in the MONEAD Study of Pregnant Women with Epilepsy.

ABSTRACT:

Objective

To determine whether growth measures at birth differ between offspring of pregnant women with epilepsy and healthy pregnant women.

Study design

The Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) study is a National Institutes of Health-funded, prospective, observational, multicenter investigation of pregnancy outcomes for mothers and their infants. Between 2012 and 2016, pregnant women with epilepsy and healthy pregnant women were enrolled at 20 US epilepsy centers. Pregnant women with epilepsy were exposed to various antiepileptic drugs. The main outcome measure was small for gestational age at birth. Principal univariate and multivariate analyses compared outcomes between pregnant women with epilepsy and healthy pregnant women. S

SUBMITTER: Van Marter LJ 

PROVIDER: S-EPMC10210636 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature